BRPI1010283A2 - salmonella enterica apresentando n-glicano de c. jejuni ou derivados dos mesmo - Google Patents

salmonella enterica apresentando n-glicano de c. jejuni ou derivados dos mesmo

Info

Publication number: BRPI1010283A2
Authority: BR; Brazil
Prior art keywords: jejuni; glycan; derivatives; showing; enteric salmonella
Prior art date: 2009-03-27

Application number

BRPI1010283A

Other languages

English (en)

Inventor

Flavio Schwarz

Karin Ilg

Markus Aebi

Saba Amber

Umesh Ahuja

Original Assignee

Eidgenoess Tech Hochschule

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-27

Filing date

2010-03-25

Publication date

2016-10-11

2010-03-25 Application filed by Eidgenoess Tech Hochschule filed Critical Eidgenoess Tech Hochschule

2016-10-11 Publication of BRPI1010283A2 publication Critical patent/BRPI1010283A2/pt

2021-04-06 Publication of BRPI1010283B1 publication Critical patent/BRPI1010283B1/pt

2021-05-25 Publication of BRPI1010283B8 publication Critical patent/BRPI1010283B8/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Immunology (AREA)
Public Health (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Cell Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Fodder In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI1010283A 2009-03-27 2010-03-25 salmonella enterica apresentando n-glicano de c.jejuni ou derivados do mesmo, seu uso, método de produção e composição farmacêutica, alimento ou ração, aditivo alimentar ou de ração compreendendo a mesma BRPI1010283B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP09004445		2009-03-27
EP09004445.4		2009-03-27
PCT/EP2010/001884 WO2010108682A1 (en)	2009-03-27	2010-03-25	Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof

Publications (3)

Publication Number	Publication Date
BRPI1010283A2 true BRPI1010283A2 (pt)	2016-10-11
BRPI1010283B1 BRPI1010283B1 (pt)	2021-04-06
BRPI1010283B8 BRPI1010283B8 (pt)	2021-05-25

Family

ID=42199060

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1010283A BRPI1010283B8 (pt)	2009-03-27	2010-03-25	salmonella enterica apresentando n-glicano de c.jejuni ou derivados do mesmo, seu uso, método de produção e composição farmacêutica, alimento ou ração, aditivo alimentar ou de ração compreendendo a mesma

Country Status (14)

Country	Link
US (2)	US9309493B2 (pt)
EP (1)	EP2411503B1 (pt)
JP (1)	JP5568626B2 (pt)
KR (1)	KR101395431B1 (pt)
CN (1)	CN102365359B (pt)
BR (1)	BRPI1010283B8 (pt)
CA (1)	CA2757224C (pt)
ES (1)	ES2646320T3 (pt)
IL (1)	IL215239A (pt)
MX (1)	MX2011009791A (pt)
PL (1)	PL2411503T3 (pt)
PT (1)	PT2411503T (pt)
RU (1)	RU2507253C2 (pt)
WO (1)	WO2010108682A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2501406T3 (pt)	2009-11-19	2018-05-19
US20140336366A1 (en) *	2011-09-06	2014-11-13	Glycovaxyn Ag	Bioconjugate vaccines made in prokaryotic cells
WO2013159234A1 (en)	2012-04-27	2013-10-31	The Governors Of The University Of Alberta	Glycoengineered outer membrane vesicles and use thereof as vaccines
RU2671473C2 (ru) *	2013-04-05	2018-10-31	Де Гавенерс Оф Де Юниверсити Оф Альберта	Вакцина против кампилобактериоза
CN103740632B (zh) *	2014-01-22	2016-02-10	山东大学	一株重组大肠杆菌及其在制备抗o157:h7的n-糖蛋白疫苗中的应用
BR112019015425A2 (pt)	2017-01-27	2020-05-26	University Of Florida Research Foundation, Incorporated	Uma vacina de segurança alimentar para controlar salmonella enterica e reduzir campylobacter em aves domésticas
WO2018167485A1 (en)	2017-03-15	2018-09-20	London School Of Hygiene And Tropical Medicine	Whole cell vaccines
PE20171768A1 (es) *	2017-06-12	2017-12-21	Farm Veterinarios S A C	Obtencion de una salmonela enteritidis tipo rugosa y sus modificaciones geneticas para uso como vacuna aviar
EP3727437A4 (en) *	2017-12-19	2021-09-08	The Governors of the University of Alberta	SURFACE GLYCANES OF CLOSTRIDIUM PERFRINGENS AND ASSOCIATED USES
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en)	2020-07-22	2026-01-27	David Gordon Bermudes	Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
CN116286580A (zh) *	2023-03-24	2023-06-23	山东大学	一种工程微生物及趋化受体的配体筛选方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6399074B1 (en) *	1998-07-24	2002-06-04	Megan Health, Inc.	Live attenuated salmonella vaccines to control avian pathogens
ATE426035T1 (de) *	2001-05-03	2009-04-15	Fit Biotech Oy	Neue expressionsvektoren und deren verwendungen
WO2004013151A2 (en) *	2002-08-01	2004-02-12	National Research Council Of Canada	Campylobacter glycans and glycopeptides
RU2237089C2 (ru) *	2002-10-31	2004-09-27	Государственный научный центр вирусологии и биотехнологии "Вектор"	Рекомбинантный аттенуированный штамм бактерий salmonella enteriditis е-23/pgex-2t-tbi как кандидат для конструирования живой вакцины против вируса иммунодефицита человека
ES2345200T3 (es) *	2003-03-24	2010-09-17	The Scripps Research Institute	Vacunas de adn contra el crecimiento tumoral y procedimientos de utilizacion de las mismas.
RU2248396C2 (ru) *	2003-04-17	2005-03-20	Государственный научный центр вирусологии и биотехнологии "Вектор"	Рекомбинантная плазмидная днк pcdna-tci, обеспечивающая экспрессию искусственного гена tci в клетках эукариот, и рекомбинантный аттенуированный штамм бактерий salmonella enteritidis e-23/pcdna-tci как кандидат для конструирования живой днк-вакцины против вируса иммунодефицита человека
EP1655370A1 (en) *	2004-11-05	2006-05-10	Gesellschaft für Biotechnologische Forschung	Bacterial vector
ES2353814T3 (es) *	2005-05-11	2011-03-07	Eth Zuerich	Proteinas n-glicosiladas recombinantes de celulas procariotas.
AU2006295017B2 (en)	2005-09-21	2010-06-17	The United States Of America As Represented By The Secretary Of The Navy	Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni

2010
- 2010-03-25 PL PL10715098T patent/PL2411503T3/pl unknown
- 2010-03-25 US US13/254,232 patent/US9309493B2/en active Active
- 2010-03-25 KR KR1020117021982A patent/KR101395431B1/ko not_active Expired - Fee Related
- 2010-03-25 WO PCT/EP2010/001884 patent/WO2010108682A1/en not_active Ceased
- 2010-03-25 MX MX2011009791A patent/MX2011009791A/es active IP Right Grant
- 2010-03-25 CN CN201080015941.2A patent/CN102365359B/zh not_active Expired - Fee Related
- 2010-03-25 CA CA2757224A patent/CA2757224C/en active Active
- 2010-03-25 RU RU2011143381/10A patent/RU2507253C2/ru active
- 2010-03-25 EP EP10715098.9A patent/EP2411503B1/en active Active
- 2010-03-25 JP JP2012501188A patent/JP5568626B2/ja not_active Expired - Fee Related
- 2010-03-25 PT PT107150989T patent/PT2411503T/pt unknown
- 2010-03-25 BR BRPI1010283A patent/BRPI1010283B8/pt not_active IP Right Cessation
- 2010-03-25 ES ES10715098.9T patent/ES2646320T3/es active Active
2011
- 2011-09-19 IL IL215239A patent/IL215239A/en active IP Right Grant
2016
- 2016-04-08 US US15/094,537 patent/US9764021B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR20110127714A (ko)	2011-11-25
US20120100177A1 (en)	2012-04-26
RU2507253C2 (ru)	2014-02-20
EP2411503B1 (en)	2017-09-13
CN102365359B (zh)	2014-10-29
CA2757224C (en)	2016-12-06
PL2411503T3 (pl)	2018-01-31
EP2411503A1 (en)	2012-02-01
WO2010108682A1 (en)	2010-09-30
JP2012521747A (ja)	2012-09-20
BRPI1010283B8 (pt)	2021-05-25
JP5568626B2 (ja)	2014-08-06
US20160213770A1 (en)	2016-07-28
CN102365359A (zh)	2012-02-29
BRPI1010283B1 (pt)	2021-04-06
US9309493B2 (en)	2016-04-12
MX2011009791A (es)	2011-10-17
CA2757224A1 (en)	2010-09-30
RU2011143381A (ru)	2013-05-10
KR101395431B1 (ko)	2014-05-14
PT2411503T (pt)	2017-11-15
US9764021B2 (en)	2017-09-19
IL215239A (en)	2016-02-29
ES2646320T3 (es)	2017-12-13
IL215239A0 (en)	2011-12-29

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-15	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-09-18	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2020-04-22	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-09-29	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-02-23	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-04-06	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2025-02-04	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2025-06-17	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI1010283A2 (pt)	2016-10-11	salmonella enterica apresentando n-glicano de c. jejuni ou derivados dos mesmo
BRPI1011459A2 (pt)	2016-03-22	embalagem de isolamento.
BR112013013584A2 (pt)	2016-09-06	endoscópio, e, método
BRPI1016117A2 (pt)	2016-04-12	derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI0913426A2 (pt)	2015-11-24	máquina de processamento de alimentos
DK2288552T3 (da)	2012-11-05	Fødevareemballage
BRPI1016079A2 (pt)	2016-05-10	escaneamento antivírus.
BRPI0911588A2 (pt)	2016-07-05	processamento de biomassa
BRPI0913059A2 (pt)	2017-05-02	processamento de biomassa
BRPI0921036A2 (pt)	2015-12-29	processamento de biomassa
EP2260162A4 (en)	2016-05-25	THROUGH SWIVEL SOLID FLOOR PLATES FROM HARDWOOD
BRPI1011134A2 (pt)	2018-02-06	turbomáquina.
BRPI0921987A2 (pt)	2018-06-05	processamento de biomassa
BRPI0917446A2 (pt)	2015-12-22	derivados de acilaminobenzamida.
BRPI0924081A2 (pt)	2018-03-20	DERIVADOS DE 5- AMINO -2-(1-hIDROXI-ETIL)- TETRAHIDROPIRANO.
BRPI1016192A2 (pt)	2016-04-19	derivados de soxazol.
DK2442870T3 (da)	2014-06-30	Pyrazinooxazepin-derivater.
IT1395219B1 (it)	2012-09-05	Otturatore per trocar e relativo trocar.
DE602007001605D1 (de)	2009-08-27	Tunnel-Pasteurisierer
BR112012003093A2 (pt)	2015-09-01	Plantas tolerantes ao estresse.
BR112012000565A2 (pt)	2016-11-16	ensaio de vírus.
BRPI0922477A2 (pt)	2015-12-15	transportador.
BRPI1015429A2 (pt)	2016-04-12	máquina de embalagem, e, método de embalagem.
BRPI0910253A2 (pt)	2015-09-29	derivados de 2-aminoquinolina
BRPI1011654A2 (pt)	2016-03-22	produto de condensação de resorcina e acetona